Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Austin, TX, USA, May 05, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Targeted DNA RNA Sequencing Market Size, Trends and Insights By Technology (NGS,...
-
UPDATED: NorthStrive Biosciences Files New U.S. Patent Application Covering EL-22 Formulations and Dosing for Treatment of Muscle-Wasting Conditions relate
-
Austin, TX, USA, April 29, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Generative AI in Chemical Market Size, Trends and Insights By Component...
-
BRANFORD, Conn., April 28, 2026 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, a clinical-stage immuno-oncology company developing a new class of multi-specific T cell engagers with integrated CD2...
-
PridCor secures global antiviral portfolio with Phase 2b and Phase 3 assets to advance treatments for Long COVID and chronic illness.
-
GREENVILLE, S.C., 22 avr. 2026 (GLOBE NEWSWIRE) -- MECART a annoncé aujourd’hui les résultats d’une analyse du cycle de vie (ACV), démontrant que ses systèmes de salles blanches présentent des...
-
Peer‑reviewed life cycle assessment shows MECART cleanroom systems have lower environmental impacts than the average North American cleanroom.
-
Phase 1 Clinical Trial of EVOLVE104 Continues to Advance According to Plan Oral Minisymposium Presentation Demonstrates That EVOLVE T Cell Engagers Drive Greater T Cell Activation, Proliferation and...
-
Austin, TX, USA, April 22, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Industrial Microwave Heating Equipment Market Size, Trends and Insights By...
-
HOUSTON, April 21, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced that an abstract highlighting data on its lead drug candidate,...